TREM2 and brucellosis: Considering that Brucellosis is a chronic infectious disease that ordinarily requires multiple antibiotics with frequent treatment failures and relapses, targeting TREM2 signaling through the downregulation of TREM2 expression or the use of TREM2 neutralizing antibodies could prove to be a promising adjunct to antibiotic therapy for the prevention of relapsing chronic infection.